MedPath

PROCARE-prevention in stationary care facilities- prevention program for caregivers

Phase 2
Conditions
M00-M99
Diseases of the musculoskeletal system and connective tissue
Registration Number
DRKS00015249
Lead Sponsor
niversität Hamburg, Arbeitsbereich Gesundheitswissenschaft
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
53
Inclusion Criteria

The study includes employees who are active in the care of residents and who have no acute and/or chronic diseases of the back.

Exclusion Criteria

Excluded are professional housekeepers, psycho-social carers and administrative staff.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcomes include the following parameters: Parameter: Lifting capacity, method of measurement: PILE Test, timepoints: Pretest, posttest after 10 weeks, posttest after 22 weeks and follow-up measurement after 34 weeks. Parameter: Predisposition of the upper body, method of measurement: Xsens, timepoints: Pretest, posttest after 10 weeks, posttest after 22 weeks and follow-up measurement after 34 weeks. Parameter: Strength endurance of lumbar extensors, method of measurement: Biering-Sorensen Test, timepoints: Pretest, posttest after 10 weeks, posttest after 22 weeks and follow-up measurement after 34 weeks.
Secondary Outcome Measures
NameTimeMethod
The secondary outcomes include the following parameters: Parameter:Total score of movement observation (wheelchair transfer), method of measurement: Movement observation sheet, timepoints: Pretest, posttest after 10 weeks, posttest after 22 weeks and follow-up measurement after 34 weeks. Parameter: Functional impairment due to back pain, questionnaire: Oswestry Disability Index, timepoints: Pretest, posttest after 10 weeks, posttest after 22 weeks and follow-up measurement after 34 weeks. Parameter: Pain intensity of back complaints, scale: VAS, timepoints: Pretest, posttest after 10 weeks, posttest after 22 weeks and follow-up measurement after 34 weeks.
© Copyright 2025. All Rights Reserved by MedPath